SHS Capital, a private equity healthcare specialist based in Tübingen, Germany, has announced the final close of its sixth fund generation at €270M, exceeding its original target of €200M due to high demand.
The fund, SHS VI, aims to support the growth of healthcare companies in Europe and will allocate between €10M and €40M per transaction.
Image: SHS Capital
With a track record of successful investment decisions and exits, SHS Capital has industry experience in healthcare and has previously taken majority stakes in companies.
As a leading private equity provider, the firm’s investment focus is on growing European healthcare champions that can generate strong revenues and returns.
Investors Supporting the New Fund
SHS Capital’s sixth fund generation has raised €270 million, exceeding the original target of €200 million due to high demand. The group of investors in SHS VI includes various entities such as fund of funds, insurance companies, pension funds, foundations, family offices, banks, healthcare corporates, church investors, and entrepreneurs. Many of SHS’s investors in previous funds have also invested in the new fund, in some cases with significantly increased subscriptions.
The SHS investment team has also made significant personal investments in the fund, highlighting their strong commitment to the firm’s investment strategies and the potential for success in the European healthcare sector.
Sascha Alilovic, SHS Managing Partner, stated that “the volume of the new fund has significantly exceeded our expectations and confirmed our positioning as the leading private equity healthcare specialist in Germany, and thus the largest European healthcare market.
Additionally, SHS was able to further internationalize its pool of investors and expand it with renowned addresses. Alilovic expressed gratitude to the investors for their trust.
The investors in SHS VI have shown confidence in the firm’s investment strategies, which focus on growing European healthcare companies.
The fund aims to back 15 to 20 companies in the healthcare sector, primarily in Germany and Europe. The investment focus of the new fund is on growth-stage companies with innovative products and technologies, which have the potential to become European healthcare champions.
SHS Capital aims to support these companies in their growth and development, providing them with access to the firm’s network of experts and resources.
SHS VI to Back 15 Companies
SHS Capital has announced the final closing of its oversubscribed sixth fund generation, SHS VI, with a total of €270 million raised. The fund aims to make 10 to 15 investments, ranging from €10M to €40M each, in collaboration with LPs and other investors. The potential transaction values can reach up to €150M.
SHS VI exclusively targets companies that already have substantial revenues, are on a growth path, and aspire to become leaders in the European healthcare sector. The fund’s investment focus is on growing European healthcare companies, emphasizing its commitment to fostering European healthcare champions.
SHS Capital leverages its healthcare industry network, deep experience, and market knowledge to support these companies in achieving their goals. Since the first closing of SHS Capital’s new fund in the previous summer, the firm has already made four investments from it, adding to a total of 13 investments and 13 exits since 2020.
The healthcare sector is an indispensable sector, offering numerous exciting opportunities for investments. With the SHS VI fund, investors have the chance to participate in the development of this growth market. SHS Capital’s track record shows attractive returns for its investors while contributing to improving the healthcare system through innovations and optimizing patient care.
In summary, SHS VI is an oversubscribed sixth fund generation that aims to make 10 to 15 investments in healthcare companies, ranging from €10M to €40M each, with the potential to reach transaction values of up to €150M.
The fund exclusively targets companies that already have substantial revenues, are on a growth path, and aspire to become leaders in the European healthcare sector. SHS Capital leverages its healthcare industry network, deep experience, and market knowledge to support these companies in achieving their goals, emphasizing its commitment to fostering European healthcare champions.
Brief about SHS Gesellschaft für Beteiligungsmanagement mbH
SHS Gesellschaft für Beteiligungsmanagement mbH (SHS Capital) is a private equity firm that specializes in investing in healthcare companies across Europe. Founded in 1993, the firm has a strong investment philosophy called “Building European Healthcare Champions”. This involves providing financial support and developmental guidance to portfolio companies.
SHS Capital is flexible in its investment approach, taking both minority and majority stakes in companies. The firm’s investments are primarily directed towards expansion financing, shareholder changes, and succession situations. Typically, the firm’s investments range up to €40M in equity or equity-like financing, but they can leverage co-investor networks for larger investments.
The investment team at SHS Capital places a strong emphasis on considering environmental, social, and governance (ESG) factors in their investment decisions, adhering to the principles outlined by the United Nations Principles for Responsible Investment (UN PRI).
The firm is headquartered in Tübingen and has a managing partner, Sascha Alilovic, who leads the investment team. The office is located at Bismarckstraße.
